Postoperative rectal ESD
Conditions
Interventions
Experimental group:The rectal ESD wound was sprayed with a new type of compound microporous polychitosan styptic powder
Control group:The wound after rectal ESD operation was not sprayed with a new type of compound microporous polychitosan styptic powder
Sponsors
Department of Endoscopy, Northern Theater General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age >=18 years old, gender is not limited; (2) Endoscopic diagnosis of rectal lesions, according to the "Chinese Consensus on Endoscopic Diagnosis and Treatment of Colorectal Cancer and precancerous Lesions (Guangzhou, 2023)" and "Expert Consensus on Endoscopic Submucosal Dissection of Digestive Tract Mucosal Lesions", patients with ESD adaptation signs: lesions with long diameter >20 mm and difficult to complete one-time resection using EMR; EMR residue >10 mm or recurrence after treatment for difficult EMR treatment; Submucosal tumor without lymph node metastasis; (3) Voluntarily participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Women during menstruation, pregnancy and lactation; (2) Previous history of colorectal surgery; (3) Patients with serious organic diseases such as cardiovascular and cerebrovascular, lung, liver and kidney; (4) Patients with blood diseases and coagulation disorders; (5) Patients with inflammatory bowel disease and adenomatosis; (6) Patients with history of taking anticoagulant drugs within 1 week before surgery; (7) Register for another clinical trial within four weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative bleeding; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of other complications; | — |
Countries
China
Contacts
Public ContactZhuo Yang
Chinese People's Liberation Army Northern Theater Command General Hospital
Outcome results
None listed